LeonaBio annual r&d spending
2019
2020
2021
2022
2023
2024
2025
LeonaBio R&D Spending Growth & History (LONA)
LeonaBio's r&d spending was $17.5M for fiscal 2025.
View full LeonaBio company overviewLeonaBio annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $17.5M | −$53.2M | −75.24% |
| 2024 | 2024-12-31 | $70.7M | −$23.1M | −24.64% |
| 2023 | 2023-12-31 | $93.8M | $32.3M | +52.59% |
| 2022 | 2022-12-31 | $61.5M | $18.7M | +43.63% |
| 2021 | 2021-12-31 | $42.8M | $29.5M | +222.10% |
| 2020 | 2020-12-31 | $13.3M | $9.5M | +250.28% |
| 2019 | 2019-12-31 | $3.8M | — | — |
LeonaBio quarterly r&d spending
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $12.7M | $9.0M | +246.95% |
| Q1 2026 | 2026-03-31 | $11.3M | $7.0M | +161.79% |
| Q4 2025 | 2025-12-31 | $6.7M | −$2.7M | −28.37% |
| Q3 2025 | 2025-09-30 | $2.8M | −$15.1M | −84.24% |
| Q2 2025 | 2025-06-30 | $3.7M | −$18.5M | −83.47% |
| Q1 2025 | 2025-03-31 | $4.3M | −$16.9M | −79.74% |
| Q4 2024 | 2024-12-31 | $9.4M | −$14.3M | −60.43% |
| Q3 2024 | 2024-09-30 | $17.9M | −$9.3M | −34.12% |
| Q2 2024 | 2024-06-30 | $22.2M | $539,000 | +2.49% |
| Q1 2024 | 2024-03-31 | $21.2M | −$57,000 | −0.27% |
| Q4 2023 | 2023-12-31 | $23.7M | $8.4M | +55.42% |
| Q3 2023 | 2023-09-30 | $27.2M | $10.2M | +60.34% |
| Q2 2023 | 2023-06-30 | $21.6M | $6.8M | +46.02% |
| Q1 2023 | 2023-03-31 | $21.3M | $6.8M | +47.25% |
| Q4 2022 | 2022-12-31 | $15.2M | $2.6M | +20.75% |
| Q3 2022 | 2022-09-30 | $17.0M | $6.3M | +58.45% |
| Q2 2022 | 2022-06-30 | $14.8M | $2.8M | +23.11% |
| Q1 2022 | 2022-03-31 | $14.5M | $7.0M | +94.22% |
| Q4 2021 | 2021-12-31 | $12.6M | $7.4M | +143.26% |
| Q3 2021 | 2021-09-30 | $10.7M | $4.9M | +83.65% |
| Q2 2021 | 2021-06-30 | $12.0M | $10.3M | +616.99% |
| Q1 2021 | 2021-03-31 | $7.4M | $6.9M | +1157.60% |
| Q4 2020 | 2020-12-31 | $5.2M | — | — |
| Q3 2020 | 2020-09-30 | $5.8M | $4.8M | +468.23% |
| Q2 2020 | 2020-06-30 | $1.7M | — | — |
| Q1 2020 | 2020-03-31 | $592,000 | — | — |
| Q3 2019 | 2019-09-30 | $1.0M | — | — |
LeonaBio r&d spending trends
Over the last five fiscal years, LeonaBio's r&d spending increased from $13.3M to $17.5M, a change of $4.2M. The latest reported quarter, Q2 2026, shows $12.7M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LeonaBio source filings ↗